By the end of 2004, the Park contained 28 biotech companies, contributing total revenue of US$76 million, representing growth of39% from the previous year. Two new companies were admitted to the Park during 2004, and were involved in the production ofpharmaceutical chemicals production, and new drug development.Additionally, the HSP biotech sector was designed to capitalize on the current advantages and core competence of integrated circuits, information technology industry, and optoelectroni
More Science Park Profiles
Additionally, the HSP biotech sector was designed to capitalize on the current advantages and core competence of integrated circuits, information technology industry, and optoelectroni
On June 3, 2014, by invitation of the Alexander von Humbold Foundation (AvH), the Germany Office of the Ministry of Science and Technology (MOST) of t...
With 37 instruments optimised for a wide range of applications, ISIS, a multidisciplinary research facility belonging to STFC, provides possible solut...
Ministry of Science and Technology 106, Sec. 2, Heping E. Rd., Taipei 10622, Taiwan, R.O.C.
Service Time: Monday to Friday, 8:30 to 17:30
Best viewed above in 1024x768 resolution